New Results

The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry

Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, Nazia Thakur, Joseph Newman, Ruthiran Kugathasan, Ksenia Sukhova, Myrsini Kaforou, Dalan Bailey, Wendy S. Barclay
doi: https://doi.org/10.1101/2021.12.31.474653

Article Information

doi 
https://doi.org/10.1101/2021.12.31.474653
History 
  • January 3, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Thomas P. Peacock1,#,
  2. Jonathan C. Brown1,#,
  3. Jie Zhou1,#,
  4. Nazia Thakur2,
  5. Joseph Newman2,
  6. Ruthiran Kugathasan1,
  7. Ksenia Sukhova1,
  8. Myrsini Kaforou1,
  9. Dalan Bailey2 and
  10. Wendy S. Barclay1,*
  1. 1Department of Infectious Disease, Imperial College London, UK, W2 1PG
  2. 2The Pirbright Institute, Woking, Surrey, UK, GU24 0NF
  1. ↵*Corresponding author: w.barclay{at}imperial.ac.uk

  1. ↵# These authors contributed equally to this work

Back to top
Posted January 03, 2022.
Download PDF
Email
The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry
Thomas P. Peacock, Jonathan C. Brown, Jie Zhou, Nazia Thakur, Joseph Newman, Ruthiran Kugathasan, Ksenia Sukhova, Myrsini Kaforou, Dalan Bailey, Wendy S. Barclay
bioRxiv 2021.12.31.474653; doi: https://doi.org/10.1101/2021.12.31.474653
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area